RAC 2.73% $1.61 race oncology ltd

Speculative M&A Transaction Analysis, page-710

  1. 552 Posts.
    lightbulb Created with Sketch. 93
    Must admit, I endeavour to follow the knowledge disseminated by many of our extremely knowledgeable investor base. The question that does stick in my mind remains, when do we see concrete interest from external parties. Will the end of year human trials lead us to where we all hope to be?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.